Dario Neri
Professor of Biomacromolecules at ETH Zürich, Co-founder of Philogen
Dario Neri is a Full Professor of Biomacromolecules at ETH Zurich, who focuses on engineering therapeutic antibodies for cancer and other angiogenesis-related disorders. He is also a co-founder of the biotech company Philogen. Neri has published about 400 articles and received numerous awards, including the ISOBM Abbott Prize, the Prous Award, and an ERC Advanced Grant.
He earned a PhD in Chemistry at the Swiss Federal Institute of Technology (ETH Zürich), under the supervision of Professor Kurt Wüthrich (Nobel Prize Chemistry 2002). He is also a co-founder of Philogen, a biotech company which has brought various antibody products into multicenter clinical trials for the treatment of cancer and of chronic inflammatory conditions.